The dCas9-KRAB repressor system was used to repress ARID5B, and the knockdown showed a significant increase in IC50 following MTX (chemodrug) treatment, suggesting that ARID5B could probably be downregulated in ALL for chemoresistance. This evidence concerns the gene ARID5B and acute lymphoblastic leukemia.